Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection

By Karin Stettler, M. Beltramello, Diego A. Espinosa, Victoria A. Graham, Antonino Cassotta, S. Bianchi, Fabrizia Vanzetta, A. Minola, S. Jaconi, F. Mele and 16 more. 2016

731 citations recorded by the source corpus.

Subfields: Infectious Diseases, Public Health, Environmental and Occupational Health

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

1. Wenshuai Wang
2. Anna Marie Pyle

Citations in the corpus

• Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2 (2020, neutral): “Recombinant S309 was expressed as a Fab in expiCHO cells transiently co-transfected with plasmids expressing the heavy and light chain, as described above (see Transient transfection) (Stettler et al., 2016).”
• Modified mRNA vaccines protect against Zika virus infection (2017, positive): “Mutation of the DII-fusion loop epitope diminishes ADE in cells and mice To evaluate whether the FL mutant vaccines diminished induction of cross-reactive enhancing antibodies, we incubated dilutions of serum obtained at 8 weeks after immunization with DENV serotype 1 (DENV-1) RVPs (Dowd et al., 201”